Qianqian Xin

Beijing, 100085, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Immunogenicity and Safety of a Live Attenuated Varicella Vaccine in Healthy Children Aged 12 to 15 Months: A Phase III, Randomized, Double-Blind, Active-Controlled Clinical Trial.

Immunogenicity and Safety of a Live Attenuated Varicella Vaccine in Healthy Children Aged 12 to 15 Months: A Phase III, Randomized, Double-Blind, Active-Controlled Clinical Trial.

Journal: Vaccines
Published: August 11, 2025

Influenza vaccines promote humoral and cellular immune responses: a randomized, double-blind, phase 3 trial.

Influenza vaccines promote humoral and cellular immune responses: a randomized, double-blind, phase 3 trial.

Journal: Nature communications
Published: January 27, 2025

Optimization of pressure swing adsorption in a three-layered bed for hydrogen purification using machine learning model.

Optimization of pressure swing adsorption in a three-layered bed for hydrogen purification using machine learning model.

Journal: Scientific reports
Published: January 16, 2025

Assessment of neutralizing antibody response as a correlate of protection against symptomatic SARS-CoV-2 infections after administration of two doses of the CoronaVac inactivated COVID-19 vaccine: A phase III randomized controlled trial.

Assessment of neutralizing antibody response as a correlate of protection against symptomatic SARS-CoV-2 infections after administration of two doses of the CoronaVac inactivated COVID-19 vaccine: A phase III randomized controlled trial.

Journal: The Journal of infection
Published: August 06, 2024

Immunogenicity and Safety of a Quadrivalent Influenza Vaccine in Population Aged 3 Years and Older in Chile and the Philippines: A Phase 3, Non-Inferiority, Double-Blind, Randomized Controlled Clinical Trial.

Immunogenicity and Safety of a Quadrivalent Influenza Vaccine in Population Aged 3 Years and Older in Chile and the Philippines: A Phase 3, Non-Inferiority, Double-Blind, Randomized Controlled Clinical Trial.

Journal: Vaccines
Published: June 21, 2024

Immune responses during COVID-19 breakthrough cases in vaccinated children and adolescents.

Immune responses during COVID-19 breakthrough cases in vaccinated children and adolescents.

Journal: Frontiers in immunology
Published: January 17, 2024

Efficacy, immunogenicity and safety of CoronaVac® in children and adolescents aged 6 months to 17 years: a multicenter, randomized, double-blind, placebo-controlled phase III clinical trial.

Efficacy, immunogenicity and safety of CoronaVac® in children and adolescents aged 6 months to 17 years: a multicenter, randomized, double-blind, placebo-controlled phase III clinical trial.

Journal: Nature communications
Published: November 22, 2023

Different Safety Pattern of an Inactivated SARS-CoV-2 Vaccine (CoronaVac®) According to Age Group in a Pediatric Population from 3 to 17 Years Old, in an Open-Label Study in Chile.

Different Safety Pattern of an Inactivated SARS-CoV-2 Vaccine (CoronaVac®) According to Age Group in a Pediatric Population from 3 to 17 Years Old, in an Open-Label Study in Chile.

Journal: Vaccines
Published: June 06, 2023

Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Immunity in Children.

Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Immunity in Children.

Journal: mBio
Published: November 16, 2022

Six-month follow-up of a booster dose of CoronaVac in two single-centre phase 2 clinical trials.

Six-month follow-up of a booster dose of CoronaVac in two single-centre phase 2 clinical trials.

Journal: Nature communications
Published: January 24, 2022

Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.

Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.

Journal: Trials
Published: September 23, 2020

The effectiveness of hypertension management in China: a community-based intervention study.

The effectiveness of hypertension management in China: a community-based intervention study.

Journal: Primary health care research & development
Published: August 18, 2020
Showing 1-12 of 18

Last Updated: 09/26/2026